1. Home
  2. IPAR vs ADPT Comparison

IPAR vs ADPT Comparison

Compare IPAR & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inter Parfums Inc.

IPAR

Inter Parfums Inc.

HOLD

Current Price

$92.58

Market Cap

3.1B

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$16.71

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPAR
ADPT
Founded
1982
2009
Country
United States
United States
Employees
647
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.5B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
IPAR
ADPT
Price
$92.58
$16.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
9
Target Price
$125.50
$17.78
AVG Volume (30 Days)
225.3K
1.6M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
3.35%
N/A
EPS Growth
7.79
63.89
EPS
4.36
N/A
Revenue
$1,317,700,000.00
$276,976,000.00
Revenue This Year
$4.60
$3.98
Revenue Next Year
$9.25
$22.72
P/E Ratio
$21.95
N/A
Revenue Growth
21.26
54.77
52 Week Low
$77.21
$6.26
52 Week High
$142.50
$20.76

Technical Indicators

Market Signals
Indicator
IPAR
ADPT
Relative Strength Index (RSI) 37.07 51.96
Support Level $92.30 $16.55
Resistance Level $101.50 $17.72
Average True Range (ATR) 3.46 0.76
MACD -1.34 0.09
Stochastic Oscillator 13.80 84.29

Price Performance

Historical Comparison
IPAR
ADPT

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: